Development and Multicenter Validation of a Novel Immune-Inflammation-Based Nomogram to Predict Survival in Western Resectable Gastric and Gastroesophageal Junction Adenocarcinoma (GEA): The NOMOGAST

Development and Multicenter Validation of a Novel Immune-Inflammation-Based Nomogram to Predict Survival in Western Resectable Gastric and Gastroesophageal Junction Adenocarcinoma (GEA): The NOMOGAST

<b>Background</b>. More than 50% of operable GEA relapse after curative-intent resection. We aimed at externally validating a nomogram to enable a more accurate estimate of individualized risk in resected GEA. <b>Methods</b>. Medical records of a training cohort (TC) and a va...

Full description

Bibliographic Details
Main Authors: Massimiliano Salati, Nicola De Ruvo, Mariano Cesare Giglio, Lorena Sorrentino, Giuseppe Esposito, Sara Fenocchi, Giovanni Cucciarrè, Francesco Serra, Elena Giulia Rossi, Giovanni Vittimberga, Giorgia Radi, Leonardo Solaini, Paolo Morgagni, Giulia Grizzi, Margherita Ratti, Fabio Gelsomino, Andrea Spallanzani, Michele Ghidini, Giorgio Ercolani, Massimo Dominici, Roberta Gelmini
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Journal of Clinical Medicine
Subjects:
gastric cancer
prognosis
nomogram
Online Access:https://www.mdpi.com/2077-0383/11/18/5439

Internet

https://www.mdpi.com/2077-0383/11/18/5439

Similar Items